Funding for this research was provided by:
National Institutes of Health (P51OD011106, R01NS076352)
Dr. Ralph and Marian Falk Medical Research Trust (na)
University of Wisconsin-Madison (NA)
Received: 11 March 2020
Accepted: 29 July 2020
First Online: 6 August 2020
Ethics approval and consent to participate
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures were performed in strict accordance with the recommendations in the National Research Council Guide for the Care and Use of Laboratory animals (2011) and were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Wisconsin-Madison (experimental protocol G00673). This article does not contain any studies with human participants performed by any of the authors.
: Not applicable.
: The authors declare that they have no competing interests. W.F. B. is co-owner and stock holder of TherVoyant and a consultant of NOUS imaging. S.-C. Z. is a co-founder of BrainXell, Inc.